Pfizer Submits FDA Emergency Approval Of Covid Pill

Pfizer CEO Albert Burla speaks at a press conference following a visit to oversee the production of the Pfizer-BioNtech COVID-19 vaccine at the US pharmaceutical company Pfizer’s plant in Puurs, Belgium on April 23, 2021.

John Tees | Swimming pool | Reuters

On Tuesday, Pfizer filed an application with the FDA for a Covid-19 pill.

The pill, if approved by the FDA, will be the first oral antiviral drug of its kind specifically designed to combat Covid, the company said.

Known as Paklovid, the pill reduces the risk of hospitalization from Covid by 89% in high-risk adults who have been exposed to the virus when taken in combination with a commonly used HIV medication, according to the company, according to the company.

“We are moving forward as quickly as possible in our efforts to place this potential treatment in the hands of patients, and we look forward to working with the US FDA to review our application together with other regulatory agencies around the world,” Pfizer said on Tuesday. director Albert Burla.

Burla previously said that Pfizer plans to submit its data to the FDA before Thanksgiving.

Earlier Tuesday, Pfizer announced it would allow generic manufacturers to ship their antiviral pills, known as Paxlovid, to 95 low- and middle-income countries.

This is the latest news. Please stay tuned.

Source link

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button